BioXcel News and Activities

BioXcel is a company listed under the stock ticker BTAI (US).

View the org chart displaying its 18 main executives

Most searched biographies at BioXcel

• Vimal Mehta, Chief Executive Officer
• Michael Miller, Board Member
• Michal Votruba, Director

Popular executive movements at BioXcel

• Mark Pavao has joined the company as Acting Chief Commercial Officer  (posted on January 12 2026).

Create your alert
to follow the executive moves at BioXcel.

BioXcel has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by BioXcel

• BioXcel Therapeutics to Highlight Novel Approaches in AI-Based Drug Candidate Discovery and Development and Advances in Neuroscience Portfolio at Virtual R&D Day :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Host Virtual R&D Day on September 23, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Announces Proposed Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• View more press releases Close

Social media about BioXcel

• BioXcel on Wikipedia, Google News & Yahoo Finance
• BioXcel on LinkedIn, X (Twitter) & YouTube